Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Mescaline
Omberacetam
4-HO-MPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Pregabalin
DOM
Experience:1050 µg 1cP-LSD - The matrix
MDAI
Experience:1000 Morning Glory seeds - Rediscovering the Self
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
3-MMC
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
DOI
4-AcO-DET
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Bufotenin
PRO-LAD
25C-NBOMe
5-MeO-DiPT
MiPT
Psilocybin mushrooms
5F-PB-22
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
5-MeO-DiBF
25D-NBOMe
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
DMT
Experience:300µg AL-LAD - Don't worry, because you're everyone!
ΑMT
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
25B-NBOH
MDA
LSD
Experience:25mg 3-MeO-PCP - Enhanced film experience
4-AcO-MET
4-HO-DPT
Experience:800 seeds LSA - My First Trip Ever
4-AcO-MiPT
Experience:120mg - Garden of The Gods
2C-C
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
2C-P
Chameleon.jpgChameleon by Anonymous.
Experience:337mg DMT fumarate - A Day With DMT
6-APDB
2C-I
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
4-HO-MET
MiPLA
Coluracetam
Ayahuasca
LSA
Experience:1mg 25c-NBOMe - Experiment in my room
1P-LSD
Phenylpiracetam
TMA-6
Experience:4x 200ug tabs - You do not need to understand
25I-NBOH
2C-T-2
MET
DPT
Enhancement of colour rose.jpgRose by Chelsea Morgan
TMA-2
AL-LAD
4-HO-DET
MDMA
Psilocin
MPT
Piracetam
DET
Phenethylamine (compound)
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
2C-E
25C-NBOH
Tree.jpgJapanese Garden by Anonymous
Βk-2C-B
JWH-018
Experience:4.5g - The Grand Introduction to Beauty and Fear
LSM-775
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Escaline
Experience:40mg - Brothermind and the Forest's Hand
LSZ
EPT
Experience:3-MeO-PCP - Extreme psychosis
ALD-52
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
5-MeO-MiPT
Amanita muscaria
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
4-AcO-DiPT
25I-NBOMe
Memantine
THJ-018
Experience:300µg LSD - Togetherness and the Silent Dusk
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Oxiracetam
Ibogaine
Bromo-DragonFLY
1P-ETH-LAD
4-HO-EPT
4-HO-DiPT
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience:250mg DXM - DXM Itch and Trip Report
4-HO-MiPT
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Paradise island by Xanny.jpgParadise island by Subsentience
4-FA
2C-D
DiPT
GABAergic hallucinogens
5-Hydroxytryptophan
Experience:4-AcO-DMT + 200mg Pill
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Selective serotonin reuptake inhibitor
Experience:4-HO-MiPT / A care free psychedelic getaway
2C-B-FLY
MDEA
Aniracetam
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
JWH-073
Proscaline
3-MeO-PCE
Pramiracetam
THJ-2201
2C-H
Experience:2 tabs DOB - My DOB Nightmare
6-APB
25B-NBOMe
2C-T-21
25N-NBOMe
5-MeO-DALT
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Allylescaline
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
3C-E
Experience:BK-2C-B - Various experiences
ETH-LAD
2C-T-7
Experience:~150mg MDA(oral) - a case of mistaken identity
1B-LSD
Cannabis
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Methallylescaline
4-AcO-DMT
PARGY-LAD
Efavirenz
DOC
DOB
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.